Azodicarbonyl dimorpholide (ADDM): an effective, versatile, and water-soluble Mitsunobu reagent
摘要:
One of the caveats of the Mitsunobu reaction is the often difficult and laborious purification of the reaction mixture. Herein, we show that azodicarbonyl dimorpholide (ADDM) is an effective and versatile Mitsunobu reagent, which, along with its reduced form ADDM-H-2, may be removed from the reaction mixture by a simple aqueous extraction. Furthermore, we demonstrate that the isolated ADDM-H-2 may be re-oxidized with silver(I) oxide to regenerate ADDM. Finally, a chromatography-free Mitsunobu reaction is presented. (C) 2013 Elsevier Ltd. All rights reserved.
Compounds of formula Ia and Ib
wherein A, B, C and R
1
are described herein.
式Ia和Ib的化合物
其中A、B、C和R1
如本文所述。
DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
申请人:Novira Therapeutics, Inc.
公开号:US20160185777A1
公开(公告)日:2016-06-30
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Substituted Fused Pyrimidinones and Dihydropyrimidinones
申请人:FRACKENPOHL Jens
公开号:US20120157306A1
公开(公告)日:2012-06-21
The use of substituted fused pyrimidinones and dihydropyrimidinones of the formula (I) or salts thereof
where the radicals of the formula (I) are each as defined in the description, for enhancing stress tolerance in plants to abiotic stress, and for invigorating plant growth and/or for increasing plant yield.
SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES
申请人:BAYER INTELLECTUAL PROPERTY GMBH
公开号:US20150173359A1
公开(公告)日:2015-06-25
The use of substituted fused pyrimidinones and dihydropyrimidinones of the formula (I) or salts thereof
where the radicals of the formula (I) are each as defined in the description, for enhancing stress tolerance in plants to abiotic stress, and for invigorating plant growth and/or for increasing plant yield.
Derivatives and methods of treating hepatitis B infections
申请人:Novira Therapeutics, Inc.
公开号:US10189835B2
公开(公告)日:2019-01-29
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.